D68.8
BillableOther specified coagulation defects
Other specified coagulation defects
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- COVID-19 associated coagulopathy
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
- coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
Code Also
A second code may be required; sequencing depends on circumstances
- , if applicable, associated condition
Also Known As / Clinical Terms
SNOMED CT
- FMFD syndrome, type V3760002
- Factors VIII, IX AND XI deficiency3760002
- Familial multiple factor deficiency syndrome, type V3760002
- Drug-induced coagulation inhibitor disorder16773005
- Abnormal fibrinolysis30257002
- Congenital fibrinogen deficiency31925001
- Hereditary factor I deficiency disease31925001
- Hereditary hypofibrinogenaemia31925001
- Hereditary hypofibrinogenemia31925001
- Factor XI inhibitor disorder38879000
- FMFD syndrome, type VI61551003
- Factor IX AND factor XI deficiency61551003
- Familial multiple factor deficiency syndrome, type VI61551003
- FMFD syndrome, type III64315007
- Factors II, VII, IX AND X deficiency64315007
- Familial multiple factor deficiency syndrome, type III64315007
- Acquired anticoagulants64509006
- Acquired coagulation factor inhibitor disorder64509006
- Circulating anticoagulant disorder64509006
- FMFD syndrome, type II65768009
- Factor VIII AND factor IX deficiency65768009
- Familial multiple factor deficiency syndrome, type II65768009
- FMFD syndrome, type IV66909001
- Factors VII AND VIII deficiency66909001
- Familial multiple factor deficiency syndrome, type IV66909001
- FMFD syndrome81783000
- Familial multiple factor deficiency syndrome81783000
- FMFD syndrome, type I84048006
- Factor V AND factor VIII deficiency84048006
- Familial multiple factor deficiency syndrome, type I84048006
- Decreased fibrinolysis87066005
- Factor IX inhibitor disorder89729000
- Disorder involving the fibrinolytic system95839005
- Disorder of fibrinolysis95839005
- Hypoplasminogenaemia95840007
- Hypoplasminogenemia95840007
- Plasminogen deficiency95840007
- Hereditary hypoplasminogenaemia95841006
- Hereditary hypoplasminogenemia95841006
- Acquired hypoplasminogenaemia95843009
- Acquired hypoplasminogenemia95843009
- Deficiency of naturally occurring coagulation factor inhibitor105604006
- Blood coagulation disorder with shortened coagulation time123786007
- Blood coagulation disorder with prolonged coagulation time123787003
- Blood coagulation disorder with shortened bleeding time123788008
- Blood coagulation disorder with prolonged bleeding time123789000
- Blood coagulation disorder with impaired clot retraction time123790009
- Blood coagulation disorder, categorised by value of screening test128088003
- Blood coagulation disorder, categorized by value of screening test128088003
- PT-VWD - platelet type-von Willebrand disease128115005
- Platelet type pseudo-von Willebrand disease128115005
- Platelet type-von Willebrand disease128115005
- Pseudo von Willebrand disease128115005
- Pseudo-von Willebrand disease type 2B128115005
- Anti-factor II disorder180481005
- Antiprothrombin disorder181456001
- Congenital fibrinogen abnormality234456000
- Hypofibrinogenaemia234457009
- Hypofibrinogenemia234457009
- Acquired fibrinogen abnormality234462005
- Combined coagulation factor deficiency234463000
- Fibrinolytic bleeding syndrome234464006
- Alpha-2-antiplasmin deficiency234465007
- Acquired coagulation disorder234466008
- Anticoagulant excess without bleeding278366008
- Afibrinogenaemia278504009
- Afibrinogenemia278504009
- Acquired inhibitor of coagulation282707003
- Acquired hypofibrinogenaemia359723007
- Acquired hypofibrinogenemia359723007
- Congenital hypofibrinogenaemia439145006
- Congenital hypofibrinogenemia439145006
- Hereditary combined coagulation factor deficiency439157002
- A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency439725008
- A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency (ADAMTS13)439725008
- Congenital alpha-2-antiplasmin deficiency716746003
- Congenital alpha2-antiplasmin deficiency716746003
- Body skin hyperlaxity due to vitamin K dependent coagulation factor deficiency717941005
- PXE (pseudoxanthoma elasticum) like syndrome717941005
- Pseudoxanthoma elasticum-like syndrome717941005
- Bleeding disorder due to calcium and DAG-regulated guanine exchange factor-1 deficiency725105006
- Bleeding disorder due to deficiency of calcium and diacylglycerol-regulated guanine nucleotide exchange factor I725105006
- ADP platelet receptor P2Y12 defect725291001
- Defect of purinergic receptor p2y G protein-coupled 12725291001
- P2Y12 (purinergic receptor p2y G protein-coupled 12) defect725291001
- P2Y12 defect725291001
- East Texas bleeding disorder773422002
- Haemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation782909004
- Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation782909004
- Familial thrombomodulin anomalies783256001
- THBD (thrombomodulin) related bleeding disorder1197595004
- Thrombomodulin-related bleeding disorder1197595004
- Thrombomodulin-related coagulopathy1197595004
- Factor V short isoforms related bleeding disorder1362024002
UMLS
- COVID-19 associated coagulopathyC5419174
- COVID-19-Associated Coagulation DisorderC5419174
- COVID-19-Associated CoagulopathyC5419174
- SARS-CoV-2-Associated Coagulation DisorderC5419174
- SARS-CoV-2-Associated CoagulopathyC5419174
- Other Specified Coagulation DefectsC0477316
- Other specified coagulation defectsC0477316
Frequently Asked Questions
What is ICD-10 code D68.8?
ICD-10-CM code D68.8 represents "Other specified coagulation defects". It is a billable/specific code that can be used on a claim.
Is D68.8 a billable code?
Yes, D68.8 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is D68.8 in?
D68.8 is in Chapter 3: Diseases of the Blood and Blood-Forming Organs (codes D50-D89).
What codes cannot be used with D68.8?
D68.8 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal coagulation profile NOS (R79.1); hemorrhagic disease of newborn (P53).
What SNOMED CT codes does D68.8 map to?
D68.8 maps to 51 SNOMED CT concepts: 439725008, 725291001, 30257002, 64509006, 234466008, and 46 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for D68.8?
D68.8 is linked to 2 UMLS Concept Unique Identifiers: C5419174, C0477316. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.